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Abstract
Background: We aimed at establishing if the substitution of vascular age (VA) for chronologi-
cal age (CA) causes a change in the Framingham Risk Score (FRS) categories. Sex differences 
in predictors of increased VA among cardiovascular (CV) risk factors and arterial stiffness 
(AS) parameters were identifi ed.
Methods: In 187 asymptomatic subjects with CV risk factors, classifi ed into 3 FRS categories 
the VA was derived from the nomograms of the carotid intima-media thickness. Two groups: 
1 — subjects whose VA has exceeded CA for at least 5 years and 2 — others were established. 
Carotid AS parameters were obtained from echo-tracking.
Results: Substitution of VA for CA changed the FRS category into the higher one in 11.8% 
of subjects. Diabetes mellitus (DM) was the predictor of increased VA in both sexes, while 
metabolic syndrome (MS) only in women. The cut-off values of AS parameters that allow for 
prediction of increased VA were determined from the ROC-curve analysis — in men: b > 7.3, 
Ep > 103 kPa, AC < 0.61 mm2/kPa after adjustment for DM, BMI > 29.1 kg/m2, WHR > 0.85 
and CA > 51 years; in women: b > 9.6, Ep > 126 kPa, AC < 0.75 mm2/kPa, PWV-b > 7.4 m/s 
after adjustment for DM, BMI > 25.8 kg/m2, WHR > 0.80 and CA > 60 years.
Conclusions: The substitution of VA for CA may increase the FRS category. Sex differences in 
predictors of increased VA were identifi ed. AS parameters proved to be predictors of increased 
VA besides the classic risk factors. (Cardiol J 2013; 20, 4: 394–401)
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Introduction
Risk algorithms, mostly based on the analysis 
of the chronological age (CA) and classic cardio-
vascular (CV) risk factors, have limitations in the 
precise CV risk assessment of an individual and 
may cause underestimation of subjects, in whom 
aggressive modifi cation of CV disease risk factors 
should be introduced [1, 2]. Therefore, the concept 
of evaluating the “vascular age” (VA) — that would 
refl ect the real atherosclerotic damage — has re-
cently drawn a growing attention in the fi eld of the 
CV risk assessment [3–6]. VA can be investigated 
by either imaging modalities like ultrasonic measu-
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rement of carotid intima-media thickness (CIMT) 
and plaque detection or by, so called, physiological 
methods like pulse wave velocity (PWV) and pulse 
wave analysis that refl ect the arterial stiffness 
(AS) [7]. AS can be considered a measure of the 
cumulative infl uence of CV risk factors with aging 
on arterial tree and may be regarded as a tissue 
biomarker [6–8].
We tested the hypothesis that the Framingham 
Risk Score (FRS) based on traditional CV risk fac-
tors does not identify subjects whose VA exceeds 
the CA for at least 5 years. We aimed at establishing 
whether the substitution of the VA for the CA in 
the FRS will cause the change in risk categories, 
the so called “reclassifi cation”. We investigated 
which of the traditional CV risk factors enable to 
predict that the VA exceeds the CA for at least 
5 years and establish if there are any sex-specifi c 
differences. We examined the relationship between 
the AS indices and the VA.
Methods
The study group consisted of 187 subjects 
(mean CA: 53.8 years [52.1–55.5]): 101 women 
(mean CA: 55.0 years [52.7–57.2]) and 86 men 
(mean CA: 52.4 years [49.9–54.9]) with CV risk 
factors and without history of manifest CV disease 
(coronary, peripheral and cerebral vascular disease 
was excluded).
The data concerning medical history of the 
study population, their risk factors, family history 
of CV disease and current pharmacological medica-
tion was obtained with the use of a questionnaire. 
Laboratory tests were performed, including: fast-
ing glucose serum level and lipids (total choleste-
rol, low-density lipoprotein cholesterol [LDL-C], 
high-density lipoprotein cholesterol [HDL-C], 
triglycerides) serum level.
All study participants were classifi ed into three 
FRS risk categories: low (< 6%), intermediate 
(6–20%) and high (> 20%) according to the 10-
-year Framingham General Cardiovascular Disease 
Risk algorithm. The algorithm takes into account 
the following factors: CA, total cholesterol serum 
level, HDL-C serum level, the value of systolic 
blood pressure (with regard if it is treated or not), 
current smoking and diabetes mellitus (DM) [9].
Metabolic syndrome (MS) was defi ned accor-
ding to the IDF defi nition [10].
The B-mode ultrasound measurement of the 
mean CIMT was performed with Aloka ProSound 
Alpha 10 machine in accordance with the Mann-
heim Protocol recommendations [11]. The VA was 
determined with the use of the regression model 
in accordance with the concept of JH Stein who 
used the gender- and race-specifi c nomograms of 
the distribution of the CIMT values in different 
age groups (the nomograms were derived from 
the Atherosclerosis Risk in Communities Study) 
and defi ned the VA as “the age at which the com-
posite CIMT value for an individual of a given race 
and gender would represent the median value 
(50th percentile)” [12–14].
The AS parameters were calculated with the 
application of the high-resolution echo-tracking 
(eT) system incorporated in Aloka ProSound 
Alpha 10 machine. After obtaining a clear image 
of the intima-media complex of both anterior and 
posterior wall of the right common carotid artery 
(CCA) in its longitudinal axis, the eT gate for the 
measurement of arterial diameter changes along 
the cardiac cycle was positioned at the boundaries 
between the intima and media of the anterior and 
posterior wall of the right CCA, 1–2 cm proximal 
to the bifurcation [15]. The proper identifi cation of 
the stages of the cardiac cycle was provided by the 
ECG monitoring. The systolic and diastolic blood 
pressure entered into the system was measured 
during the eT procedure (the patient in a supine 
position for at least 15 min) at the left brachial 
artery. Three to fi ve beats were averaged to obtain 
a representative waveform. The following AS pa-
rameters were calculated automatically [16]:
— b — beta, beta stiffness index [U]: 
 b = ln (Ps/Pd)/[(Ds – Dd)/Dd];
— Ep — Peterson’s modulus [kPa]: 
 Ep = (Ps – Pd)/[(Ds – Dd)/Dd];
— AC — arterial compliance [mm2/kPa]:
 AC = p(Ds × Ds – Dd × Dd)/[4 × (Ps – Pd)];
— PWV-b — one-point pulse wave velocity [m/s]: 
PWV-b= √(b × Ps/2 × r),
where: ln — the natural logarithm, Ps — systolic 
blood pressure, Pd — diastolic blood pressure, Ds 
— arterial systolic diameter, Dd — arterial diastolic 
diameter, r — blood density (1.050 kg/m3) (Fig. 1).
Reproducibility of these measurements has 
been reported elsewhere [17].
All participants provided written informed 
consent. The study was approved by the ethics 
committee of Medical University of Wroclaw.
Statistical analysis
The statistical analysis of the collected results 
has been performed using the software package 
STATISTICA v.9. The analysis included: for quan-
titative features — accuracy of normal distribution 
has been verifi ed with Shapiro-Wilk’s and c2 tests, 
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basic statistics have been calculated (mean, 95% 
confi dence interval [CI]); for qualitative (nomi-
nal) features — occurrence frequency (fractions) 
has been calculated; signifi cance of differences 
between means in two groups (differed in sex or 
differed in calendar age CA and vascular age VA) 
Figure 1. Measurement of arterial stiffness parameters with echo-tracking; A. Positioning of the echo-tracking gate 
in the right common carotid artery (CCA); B. The curve of the right CCA diameter changes obtained with the echo-
-tracking system; D min — minimal arterial diameter; D max — maximal arterial diameter; C. Arterial stiffness para-
meters: b — beta stiffness index; Ep — Peterson’s modulus; AC — arterial compliance; AI — augmentation index; 
PWV-b — one-point pulse wave velocity; PWV_WI — pulse wave velocity wave intensity.
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has been verifi ed with Mann-Whitney’s nonpara-
metric test or t-test for independent variables; 
signifi cance of differences in occurrence frequency 
of specifi ed nominal or categorized variables sub-
groups has been verifi ed with Pearson’s c2 test 
or with Fisher’s exacts test. Both values of odds 
ratio and their 95% CI have been estimated. For 
quantitative variables that showed a statistically 
significant difference between the two groups, 
receiver-operating characteristic (ROC) curves 
were obtained to calculate the cut-off values optimi-
zed to reach the best compromise in the prediction 
of the increased VA. Optimal cut-off was defi ned 
as a threshold where the sum of sensitivity and 
specifi city was maximum. Value p < 0.05 has been 
accepted as a critical level for all statistical tests.
Results
The detailed patient clinical characteristics 
have been presented in Table 1. The prevalence of 
the traditional CV risk factors like: hypertension, 
smoking and hypercholesterolemia did not differ 
between men and women, while DM occurred more 
frequently in men and MS in women.
Framingham Risk Score: Reclassifi cation 
The 10-year FRS was higher in men than 
in women (20.4% vs. 11.1%, p < 0.001) and the 
analysis of the risk categories revealed that more 
women than men were classified in a low-risk 
group (29.7% vs. 11.6%, p = 0.005), while more 
men — in comparison to women — belonged to 
a high-risk group (54.7% vs. 22.8%, p < 0.001). 
The mean VA of the whole population significan-
tly exceeded the mean CA (59.9 years; 56.0–63.8 
vs. 53.8 years; 52.1–55.5; p < 0.05), and the 
mean difference value was about 6.1 years. An 
analogous trend, even more pronounced, was 
observed in men (61.9 years; 56.5–67.4 vs. 
52.4 years; 49.9–54.9; p < 0.001), with a mean 
difference about 9.5 years. In women the dif-
ference between VA and CA did not reach the 
statistical significance.
The study material was divided into two 
groups: group 1 — individuals whose VA exceeded 
Table 1. Patient clinical characteristics.
Women (n = 101) Men (n = 86) Total (n = 187) P
Chronological age [years] 55.0 (52.7–57.2) 52.4 (49.9–54.9) 53.8 (52.1–55.5) 0.129
Hypertension 47 (46.5%) 45 (52.3%) 92 (49.2%) 0.520
Diabetes mellitus type 2 37 (36.6%) 46 (53.5%) 83 (44.4%) 0.030
Smoking 35 (34.7%) 36 (41.9%) 71 (38.0%) 0.389
Hypercholesterolemia 63 (62.4%) 53 (61.6%) 116 (62.0%) 0.963
Metabolic syndrome 48 (47.5%) 15 (17.4%) 37 (33.7%) < 0.001
Heart rate [min-1] 73.4 (71.5–75.3) 68.7 (66.6–70.8) 71.2 (69.8–72.7) 0.001
Systolic BP [mm Hg] 132 (128–136) 133 (130–136) 133 (130–135) 0.354
Diastolic BP [mm Hg] 77 (75–79) 75 (73–77) 76 (74–77) 0.181
Pulse pressure [mm Hg] 55 (52–59) 59 (56–61) 57 (55–59) 0.026
Fasting glucose [mg/dL] 97 (94–101) 100 (95–105) 98 (95–101) 0.403
Total cholesterol [mg/dL] 217 (208–226) 205 (196–213) 211 (205–217) 0.082
LDL-C [mg/dL] 129 (121–137) 127 (119–135) 128 (122–134) 0.942
HDL-C [mg/dL] 62 (58–65) 50 (47–53) 56 (54–59) < 0.001
Triglycerides[mg/dL] 150 (132–169) 146 (126–165) 148 (135–161) 0.704
Total/high density 
lipoprotein ratio
3.76 (3.51–4.00) 4.38 (4.06–4.69) 4.04 (3.84–4.24) < 0.001
Body mass index [kg/m2] 27.9 (26.9–29.0) 28.8 (27.9–29.7) 28.3 (27.7–29.0) 0.128
Waist circumference [cm] 87 (84–91) 102 (98–106) 93 (90–96) < 0.001
Waist to hips ratio 0.82 (0.80–0.84) 0.94 (0.92–0.97) 0.87 (0.85–0.89) < 0.001
FRS [%] 11.1 (9.3–13.0) 20.4 (18.1–22.7) 15.4 (13.8–17.0) < 0.001
FRS category low 30 (29.7%) 10 (11.6%) 40 (21.4%) 0.005
FRS category intermediate 48 (47.5%) 29 (33.7%) 77 (41.2%) 0.078
FRS category high 23 (22.8%) 47 (54.7%) 70 (37.4%) < 0.001
BP — blood pressure; LDL-C — low density lipoprotein cholesterol; HDL-C — high density lipoprotein cholesterol; FRS — Framingham 
Risk Score
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the CA for at least 5 years, and group 2 — others, 
separately for sex. To group 1 belonged 85 (45%) 
subjects: 47 (55%) men and 38 (38%) women. The 
statistical analysis revealed that men belonged to 
group 1 more frequently than women (p = 0.029).
The important observation was that in both 
sexes the FRS category did not differentiate be-
tween individuals who belonged to group 1 and to 
group 2 (Table 2).
The upgrade into the higher CV risk catego-
ry — the so called “reclassifi cation” occurred in 
22 subjects (11.8% of the whole population; Table 3). 
The sex analysis revealed that men underwent 
reclassifi cation more frequently than women (18.6% 
vs. 5.9%, p = 0.0142); Twenty one (95%) of the in-
dividuals who underwent reclassifi cation belonged 
to group 1.
Predictors of subjects in whom the 
VA exceeded the CA for at least 5 years: 
Sex differences
The analysis of the  predictors of the VA 
exceeding the CA for at least 5 years performed 
separately for men and women revealed that DM 
was a predictor in both sexes, although a stronger 
one in women (women: OR 3.63, p = 0.005; men: 
OR 2.54, p = 0.058). To the additional predictors in 
women belonged: MS (OR 4.01, p = 0.009), waist 
to hip ratio (WHR) > 0.80 (OR 17.3, p = 0.003) 
and body mass index (BMI) > 25.8 (OR 3.52, p = 
= 0.012; Table 4). The cut-off values were determined 
from the ROC curve.
Relationships between arterial stiffness 
parameters and vascular age
The AS parameters in men, except for the arte-
rial compliance, showed linear correlation with the 
CA. In women almost all AS parameters correlated 
positively linearly with the VA (except for the arte-
rial compliance that showed negative correlation), 
while in men it was only b and Ep (Table 5).
The cut-off values of the AS parameters that 
allow for the prediction of increased VA were de-
termined from the ROC-curve analysis (Table 6). 
Of noteworthy is that the cut-off values in men 
were lower than in women.
Table 2. Relationship between the Framingham Risk Score (FRS) categories and vascular age.
FRS category Men (n = 86) Women (n = 101) Total (n = 187)
Group 1 
 VA–CA ≥ 5 
N = 47
Group 2
Others 
N = 39
Group 1
VA–CA ≥ 5 
N = 38
Group 2
Others 
N = 63
Group 1
VA–CA ≥ 5 
N = 85
Group 2
Others 
N = 102
Low 6 (12.8%) 4(10.3%) 11 (28.9%) 19 (30.2%) 17 (20.0%) 23 (22.5%)
Intermediate 12 (25.5%) 17 (43.6%) 17 (44.7%) 31 (49.2%) 29 (34.1%) 48 (47.1%)
High 29 (61.7%) 18 (46.2%) 10 (26.3%) 13 (20.6%) 39 (45.9%) 31 (30.4%)
c2 test: 
c2 = 3.12; df = 2; p = 0.210
c2 test: 
c2 = 0.45; df = 2; p = 0.800
c2 test: 
c2 = 4.60; df = 2; p = 0.100
VA — vascular age; CA — chronological age
Table 3. Reclassification — change of the Framingham Risk Score (FRS) category into the higher one 
after the substitution of the vascular age for the chronological age.
Total (n = 187) Men (n = 86) Women (n = 101) P
Calendar age [years] 53.8 (52.1–55.5) 52.4 (49.9–54.9) 55.0 (52.7–57.2) 0.129
Vascular age [years] 59.9 (56.0–63.8) 61.9 (56.5–67.4) 58.1 (52.5–63.6) 0.202
Reclassification 22 (11.8%) 16 (18.6%) 6 (5.9%) 0.0142
Group 1 
(n = 47)
Group 2 
(n = 39)
P Group 1 
(n = 38)
Group 2 
(n = 63)
P
15 (31.9%) 1 (2.6%) 0.0005 6 (15.8%) 0 (0%) 0.0022
FRS category 
low Æ intermediate
9 4 (8.5%) 1 (2.6%) 4 (10.5%) 0
FRS category 
intermediate Æ high
13 11 (23.4%) 0 2 (5.3%) 0
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Discussion
Nowadays we are witnessing the revival of the 
idea: “a man is as old as his arteries” in the concept 
of the “vascular age” [3–7, 13, 14, 18].
Framingham Risk Score: Reclassifi cation
FRS is useful in the population risk assessment 
but is not helpful in the individual risk evaluation. 
Table 6. The cut-off values of the arterial stiffness parameters in prediction of the vascular age exceeding 
the chronological age for at least 5 years.
Men Women
Stiffness parameters Pa Odds ratiob Stiffness parameters Pa Odds ratioc
b > 7.3 0.0003 6.46 (4.07–10.2) b > 9.6 0.0001 6.92 (4.34–11.0)
Ep > 103 kPa 0.0199 3.00 (1.98–4.56) Ep > 126 0.0032 4.38 (2.86–6.71)
AC < 0.61 mm2/kPa 0.0463 2.81 (1.85–4.26) AC < 0.75 mm2/kPa 0.0439 2.76 (1.83–4.16)
PWV-b > 6.0 m/s 0.0627 2.43 (1.61–3.68) PWV-b > 7.4 m/s 0.0103 4.28 (2.62–6.99)
ac2 test; badjusted odds ratio for diabetes, chronological age > 51 years; WHR > 0.85 and BMI > 29.1 kg/m2; cadjusted odds ratio for diabetes, 
chronological age > 60 years, WHR > 0.80 and BMI > 25.8 kg/m2; b — beta stiffness index; Ep — Peterson’s modulus; AC — arterial 
compliance; PWV-b — one-point pulse wave velocity
Table 4. Predictors of the vascular age exceeding the chronological age for at least 5 years in men and 
women.
Men (n = 86) Women (n = 101)
Pa OR (95% CI) Pa OR (95% CI)
Hypertension 0.694 1.30 (0.56–3.05) 0.940 0.89 (0.40–2.00)
Diabetes mellitus 0.058 2.54 (1.06–6.07) 0.005 3.63 (1.54–8.53)
Smoking 0.60 6 0.72 (0.31–1.71) 0.249 0.54 (0.22–1.31)
Metabolic syndrome 0.863 1.30 (0.42–4.05) 0.009 4.01 (1.49–10.8)
Hypercholesterolemia 0.836 0.83 (0.34–1.98) 0.174 0.52 (0.23–1.18)
WHR > 0.93b 0.076 4.00 (1.06–15.1)
WHR > 0.80b 0.003 17.3 (2.10–143)
BMI > 29.1 kg/m2c 0.319 1.71 (0.72–4.08)
BMI > 25.8 kg/m2c 0.012 3.52 (1.39–8.87)
ac2 test; bthe cut-off value from the ROC curve: for men AUC = 0.627, for women AUC = 0.662; cthe cut-off value from the ROC curve: for 
men AUC = 0.553, for women AUC = 0.624; OR — odds ratio; CI — confidence interval; WHR — waist to hips ratio; BMI — body mass 
index
Table 5. Linear correlation between arterial stiffness parameters and chronological and vascular age in 
men and women.
Men Women
b Ep AC PWV-b b Ep AC PWV-b
CA r = 0.420 r = 0.398 r = –0.180 r = 0.391 r = 0.416 r = 0.441 r = –0.379 r = 0.484
p < 0.001 p < 0.001 p = 0.096 p = 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
VA r = 0.304 r = 0.320 r = –0.048 r = 0.150 r = 0.593 r = 0.538 r = –0.229 r = 0.421
p = 0.005 p = 0.003 p = 0.661 p = 0.167 p < 0.001 p < 0.001 p = 0.022 p < 0.001
CA — chronological age; VA — vascular age; b — beta stiffness index; Ep — Peterson’s modulus; AC — arterial compliance; 
PWV-b — one-point pulse wave velocity
Various reports have provided evidence that athe-
rosclerosis in form of increased CIMT, plaques and 
coronary artery calcium score > 0 can be found in 
asymptomatic subjects classifi ed as at low — or 
intermediate CV risk [19, 20]. Framingham CV 
risk estimates are infl uenced strongly by the CA. 
Integrating VA in the risk algorithms could be an 
attractive concept for subjects whose risk was 
estimated as low or intermediate according to 
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the traditional risk scores. In our study the FRS 
categories did not differentiate between individu-
als with increased VA and others — the fi nding 
consistent with the previous studies [19, 20]. Our 
results confi rmed the thesis that VA represents 
the atherosclerotic burden which varies between 
individuals with the same CA despite similar CV 
risk profi les [18].
In our study 11.8% of the population was 
reclassifi ed into the higher FRS category after 
substitution of VA for CA. In the report by Stein  et 
al. [13] the proportion of subjects who underwent 
reclassifi cation into the higher risk category was 
comparable (15%). We observed a stronger ten-
dency for reclassifi cation in men. This fi nding was 
consistent with the results of the study by Gepner 
et al. [21] performed on a population of asympto-
matic and non-diabetic subjects, in which the male 
sex belonged to the predictors of the rise in CV risk 
for at least 5%. This shows that the assessment 
of the VA helps identify individuals whose CV risk 
might be underestimated.
Predictors of the VA exceeding the CA 
for at least 5 years: Sex differences
The present study revealed a few interesting 
issues concerning sex differences in predictors 
of the VA exceeding the CA for at least 5 years. 
First of all, in our population DM was the only 
predictor of increased VA common for both men 
and women (with a stronger infl uence in females). 
One of the possible mechanisms that accounts for 
elevated CV risk and increased VA in individuals 
with abnormal glucose metabolism leads through 
increased AS [22]. Then, MS and its components: 
elevated BMI and WHR were proved to be predic-
tive for increased VA only in females. This could 
be partly explained by the fact that our female 
population belonged mainly to the middle-aged 
group (perimenopausal women) — which is cha-
racterized by the clustering of various risk factors. 
It has been shown in literature that the effect of 
MS on the development of early atherosclerosis 
usually expressed by thickened CIMT is more 
pronounced in women than in men. There have 
already been a few reports providing evidence 
that MS accelerates the age-dependent increase in 
CIMT and AS parameters and that its infl uence on 
vascular structure and function is independent of 
its individual components and results mainly from 
the clustering of risk factors [23, 24].
In the present study no association between 
the HDL-C or LDL-C serum levels and VA was 
established, which might be caused by the fact that 
6% of the study population was on lipid-lowering 
therapy. In the report by Stein et al. [13] HDL-C 
and LDL-C serum levels were proved to be predic-
tors of the upgrade of the coronary heart disease 
risk category into the higher one.
The surprising fi nding of our study was that 
systolic blood pressure was not a predictor of the 
VA exceeding the CA for at least 5 years. In the 
report by Stein et al. [13] systolic blood pressure 
was proved to be a weak predictor of increased VA 
(of noteworthy is that in the study by Stein et al. 
[13] increased VA was the VA exceeding the CA 
for at least 10 years).
Relationships between AS parameters and VA
Vascular stiffening is an integral part of the 
“normal” vascular aging. It is mainly caused by the 
degeneration of elastic lamellae and overproduction 
of abnormal collagen in the arterial wall [25].
O’Rourke [26] suggests that atherosclerosis 
should be evaluated in 2 aspects: atherosis which 
refl ects structural changes of the arterial wall and 
sclerosis — concerned with functional changes. 
CIMT is a marker of atherosis, while AS refl ects 
sclerosis. The novel high resolution eT method 
enables simple, noninvasive assessment of the 
AS and it correlates with the carotid-femoral PWV, 
which is a gold standard in the assessment of the 
AS [8].To our best knowledge, this the fi rst report 
concerned with the relationship between AS mea-
sured by eT and VA.
In our study AS parameters measured at the 
CCA correlated with the CA, the fi nding that was 
consistent with the literature [27]. One of the 
strengths of our study was the investigation of 
the relationship between the AS parameters and 
CIMT-derived VA. Our novel approach enabled 
an integrated evaluation of the structural and 
functional arterial changes. We proved that AS 
parameters correlated with the VA. Furthermore, 
we identifi ed the cut-off values of some of the AS 
parameters that allowed for the prediction of the 
VA exceeding the CA for at least 5 years (from the 
ROC curve after adjustment for other risk factors 
such as: DM, BMI, WHR and CA).
As it was mentioned earlier, AS refl ects the 
process of the physiological vascular aging. Howe-
ver, it can be accelerated by variable damaging fac-
tors that interact with the vascular wall throughout 
the whole life of an individual. The measurement of 
the AS parameters provides the information on the 
present condition of the arterial wall. Therefore, 
the assessment of AS parameters can be a good 
method for the evaluation of the VA.
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Limitations of the study
The present study has an observational, cross-
-sectional design. The sample was entirely Cauca-
sian. The AS parameters were calculated from al-
gorithms that include the change in CCA diameter 
and the value of blood pressure measured at the 
brachial artery not at the CCA, which may affect 
the measurement of the AS parameters because 
carotid and brachial pressure is not identical due 
to the phenomenon of the central to peripheral 
blood pressure amplifi cation, pronounced especial-
ly in young people. Our sample consisted mostly 
of middle-aged subjects. Because there was no 
follow-up of the study population, the relationships 
between the study results and subsequent CV 
events remains unknown. The signifi cance of the 
estimation of the VA is still unclear.
Conclusions
The substitution of the VA for the CA may 
cause the change of the FRS category into the 
higher one. There are sex-related differences in 
predictors of increased VA. AS parameters proved 
to be predictors of increased VA besides the classic 
risk factors. The results of our study suggest that 
integrative approach to CV risk assessment — that 
incorporates markers of structural and functional 
vascular parameters into risk algorithms — might 
be benefi cial. Future studies will be needed to 
establish the prognostic value of VA.
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